Cargando…
Anticoagulant therapy in patients with congenital FXI deficiency
The bleeding phenotype of factor XI (FXI) deficiency is unpredictable. Bleeding is usually mild and mostly occurs after injury. Although FXI deficiency renders antithrombotic protection, some patients might eventually develop thrombosis or atrial fibrillation, requiring anticoagulant therapy. There...
Autores principales: | Bravo-Pérez, Carlos, Serna, María Jose, Esteban, Julio, Fernandez-Mellid, Eugenia, Fontanes-Trabazo, Emilia, Lorenzo, Alvaro, Calviño-Suárez, Michael, Miñano, Antonia, Padilla, José, Roldán, Vanessa, Vicente, Vicente, Corral, Javier, de la Morena-Barrio, María Eugenia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945614/ https://www.ncbi.nlm.nih.gov/pubmed/34597376 http://dx.doi.org/10.1182/bloodadvances.2021005695 |
Ejemplares similares
-
P1681: FXI LEVELS AS INDEPENDENT RISK FACTOR FOR THROMBOSIS/OBSTETRIC EVENTS IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES
por: De La Morena-Barrio, M. E., et al.
Publicado: (2022) -
Transient desialylation in combination with a novel antithrombin deficiency causing a severe and recurrent thrombosis despite anticoagulation therapy
por: Revilla, Nuria, et al.
Publicado: (2017) -
ALG12‐CDG: An unusual patient without intellectual disability and facial dysmorphism, and with a novel variant
por: de la Morena‐Barrio, María Eugenia, et al.
Publicado: (2020) -
Usefulness and Limitations of Multiple Ligation-Dependent Probe Amplification in Antithrombin Deficiency
por: Cifuentes, Rosa, et al.
Publicado: (2023) -
Factor XI in Carriers of Antiphospholipid Antibodies: Elevated Levels Associated with Symptomatic Thrombotic Cases, While Low Levels Linked to Asymptomatic Cases
por: Pagán-Escribano, Javier, et al.
Publicado: (2023)